SCHEMBL7946450

SCHEMBL7946450

NC(=O)c1cc(-c2cccnc2Cl)n2c1SCC2

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.36
SMN1; SMN2 Q16637 4/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 3/20 0.34
ALDH1A1 P00352 3/20 0.34
KDM4E B2RXH2 2/20 0.34
HSD17B10 Q99714 1/20 0.34
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
KMT2A Q03164 1/20 0.33
ADRA1D P25100 1/20 0.33
DHODH Q02127 1/20 0.33
MAP4K2 Q12851 1/20 0.33
PARP1 P09874 1/20 0.33
MAPT P10636 1/20 0.32
POLB P06746 1/20 0.32
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7957597 0.77 HPGD (0.37) RAB9ASMN1; SMN2LMNAHPGDALDH1A1
SCHEMBL7955658 0.77 MEN1 (0.35) RAB9ASMN1; SMN2LMNAHPGDALDH1A1
SCHEMBL7946462 0.76 CYP11B2 (0.36) RAB9AHPGDALDH1A1HSD17B10MEN1
SCHEMBL10744080 0.76 MKNK1 (0.46) KMT2A
SCHEMBL8329574 0.74 PTPN11 (0.33) RAB9ASMN1; SMN2LMNAALDH1A1KDM4E
SCHEMBL8330014 0.67 SMN1; SMN2 (0.43) RAB9ASMN1; SMN2LMNAALDH1A1KDM4E
SCHEMBL30680438 0.65 SMN1; SMN2 (0.68) RAB9ASMN1; SMN2LMNAHPGDALDH1A1
SCHEMBL38770 0.65 SMN1; SMN2 (0.68) RAB9ASMN1; SMN2LMNAHPGDALDH1A1
Hydrochloric Acid SCHEMBL5008498 0.64 SMN1; SMN2 (0.66) RAB9ASMN1; SMN2LMNAHPGDALDH1A1
Hydrochloric Acid SCHEMBL28905020 0.64 SMN1; SMN2 (0.66) RAB9ASMN1; SMN2LMNAHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6194426-B1 CONTROLLING TUMOR NECROSIS FACTOR RHONA-POULENC RORER S.A. (FR) 2001-02-27 US disclosed
EP-0833635-A1 NOVEL USE FOR PYRROLE DERIVATIVES Aventis Pharma S.A. (FR) 1998-04-08 EP disclosed
WO-1997000073-A1 NOVEL USE FOR PYRROLE DERIVATIVES RHONE-POULENC RORER S.A. (FR) 1997-01-03 WO disclosed